The University of Utah received a $2,856,242 project grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke to develop noninvasive targeted neuromodulation techniques. The grant is funded through the 21st Century Cures Act Brain Research through Advancing Innovative Neurotechnologies program.
Under the award, the University will perform research in non-human primates to determine effective stimulation parameters for modulating deep brain circuits noninvasively. Researchers will target visual regions to assess neuromodulatory effects using electrophysiological methods. Safety validation will include behavioral tasks, MRI imaging, and histological examination. Completion of this work will maximize the effectiveness and validate the safety of a new non-invasive targeted neuromodulation approach with the potential to provide treatment options for medication-resistant patients. The grant period is from August 1, 2022 to July 31, 2025.
Generated 1/6/24, 3:37 PM